Loading market dashboard
Pfizer Inc.
PFEHealthcareNYSEUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Pfizer Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $53.81B | $51.75B - $55.67B | $15.87B | $2.404 | 11 |
| Dec 2029 | $53.02B | $50.99B - $54.85B | $15.63B | $2.314 | 15 |
| Dec 2028 | $54.70B | $54.39B - $55.01B | $16.13B | $2.431 | 22 |
| Dec 2027 | $59.20B | $56.54B - $61.02B | $17.46B | $2.832 | 19 |
| Dec 2026 | $61.74B | $60.52B - $62.80B | $18.21B | $2.961 | 19 |
| Dec 2025 | $61.94B | $61.61B - $62.08B | $18.26B | $3.119 | 13 |
| Dec 2024 | $63.08B | $62.67B - $63.64B | $18.60B | $2.926 | 14 |
| Dec 2023 | $55.17B | $53.06B - $57.07B | $16.27B | -$0.459 | 13 |
| Dec 2022 | $100.34B | $98.17B - $101.96B | $25.25B | $6.503 | 4 |
| Dec 2021 | $81.76B | $80.00B - $83.09B | $25.34B | $4.208 | 5 |
| Dec 2020 | $48.20B | $47.16B - $48.98B | $14.90B | $2.831 | 5 |
| Dec 2019 | $51.68B | $50.56B - $52.51B | $21.36B | $2.969 | 4 |